Bilcare shareholders approve Ashwini Hasabnis as Independent Director
Bilcare Limited shareholders overwhelmingly approved the appointment of Mrs. Ashwini Ashok Hasabnis as an Independent Director for five years. The special resolution passed with 99.94% support, with promoters casting all their votes in favour and public shareholders showing 97.32% support. The process was conducted via remote e-voting between June 23 and July 22, 2026, with Mr. Shekhar Ghatpande serving as scrutinizer.

*this image is generated using AI for illustrative purposes only.
Bilcare Limited shareholders have approved the appointment of Mrs. Ashwini Ashok Hasabnis as a Non-Executive Woman Independent Director for a term of five years. The special resolution received overwhelming support, with 99.94% of votes cast in favour and only 0.06% against, marking a decisive endorsement of the Board’s governance structure. The appointment strengthens the company’s independent oversight capabilities as it continues to operate in the healthcare sector.
The resolution was transacted through a postal ballot process conducted via remote e-voting, compliant with Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The e-voting window remained open from June 23, 2026, at 09:00 A.M. IST to July 22, 2026, at 05:00 P.M. IST. Shareholders holding equity shares on the record date of June 12, 2026, were eligible to vote. Mr. Shekhar Ghatpande, Partner at Ghatpande & Ghatpande Associates, served as the scrutinizer for the process and submitted his report on July 23, 2026.
Voting Results Breakdown
The total number of shares held by eligible shareholders stood at 23,545,231. Of these, 5,994,442 shares voted, representing a participation rate of 25.46%. The promoter group held 7,066,611 shares and cast all 5,861,489 polled votes in favour of the resolution. Public non-institutional shareholders held 16,468,620 shares; of the 132,953 votes polled from this category, 129,387 were in favour and 3,566 were against.
| Category | Shares Held | Votes Polled | Votes In Favour | Votes Against | % Support |
|---|---|---|---|---|---|
| Promoter Group | 7,066,611 | 5,861,489 | 5,861,489 | 0 | 100.00% |
| Public Institutions | 10,000 | 0 | 0 | 0 | 0.00% |
| Public Non-Institutions | 16,468,620 | 132,953 | 129,387 | 3,566 | 97.32% |
| Total | 23,545,231 | 5,994,442 | 5,990,876 | 3,566 | 99.94% |
As per Section 114 of the Companies Act, 2013, a special resolution requires votes cast in favour to be three times more than those cast against. With 5,990,876 votes in favour versus 3,566 against, the resolution comfortably met this threshold. The scrutinizer’s report confirmed that no invalid votes were recorded during the process.
Governance Implications
The appointment of Mrs. Hasabnis, identified by DIN 07766525, adds to Bilcare’s independent director strength, ensuring compliance with corporate governance norms regarding board composition. The high level of support from both promoter and public shareholders indicates strong confidence in the candidate’s qualifications and the Board’s selection process. The remote e-voting mechanism facilitated broad participation without the need for physical meetings, aligning with regulatory pushes for digital shareholder engagement. The voting results and scrutinizer’s report are available on the company’s website and the portal of MUFG Intime India Pvt. Ltd., the Registrar and Share Transfer Agent.
Historical Stock Returns for Bilcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.64% | -5.95% | +4.00% | -6.95% | -6.95% | -6.95% |
How will Mrs. Hasabnis's specific expertise influence Bilcare's strategic direction in the evolving healthcare sector?
What impact might the addition of an independent woman director have on Bilcare's ESG ratings and investor appeal?
Does the low participation rate of 25.46% among eligible shareholders signal apathy or a need for improved investor engagement strategies?


































